Haemonetics (HAE) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.92 --0%
Revenue Growth %: +5.5%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.5%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.77, $0.07 better than the analyst estimate of $0.70. Revenue for the quarter came in at $304 million versus the consensus estimate of $290.79 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Oil near $100, Fed rate fears and Iran tensions - what’s moving markets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
